Cynata Therapeutics Limited Share Price
Stocks
CYP
AU000000CYP7
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
08:18:26 05/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.0110 AUD | 0.00% |
|
0.00% | -96.81% |
| 28/09 | Cynata Therapeutics Limited Auditor Raises 'Going Concern' Doubt | CI |
| 31/08 | Cynata Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| Market Cap | 26.78L 18.7L 16.6L 15.53L 14.08L 26.59L 18Cr 1.87Cr 72.56L 9.19Cr 70.18L 68.68L 30Cr | P/E 2025 |
-3.27x | P/E 2026 | -0.36x |
|---|---|---|---|---|---|
| Enterprise Value | 17.81L 12.43L 11.04L 10.33L 9L 17.68L 12Cr 1.24Cr 48.24L 6.11Cr 46.66L 45.66L 20Cr | EV / Sales 2025 |
15.3x | EV / Sales 2026 | 1.47x |
| Free-Float |
75.03% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| CYP | Delayed | |
OTC Markets
| CYYNF | Delayed | |
|
Deutsche Boerse AG
| 51S | Delayed | |
|
Börse Stuttgart
| 51S | Delayed |
Last Transcript: Cynata Therapeutics Limited
| 3 months | -31.25% | ||
| 6 months | -96.27% | ||
| Current year | -96.81% |
| 1 week | 0.01 |  | 0.01 |
| 1 month | 0.01 | | 0.01 |
| Current year | 0.01 | | 0.44 |
| 1 year | 0.01 | | 0.44 |
| 3 years | 0.01 | | 0.44 |
| 5 years | 0.01 | | 0.64 |
| 10 years | 0.01 | | 1.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mathias Kroll
PRN | Corporate Officer/Principal | - | 01/04/2024 |
Peter Webse
SEC | Corporate Secretary | 63 | 18/05/2012 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Wotton
CHM | Chairman | 65 | 28/02/2017 |
Kilian Kelly
BRD | Director/Board Member | - | 01/07/2023 |
Geoff Brooke
CHM | Chairman | 70 | 18/08/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/06/23 | Buy | Chief Executive Officer | 55,813 | 0.0312% | ||
| 01/06/23 | Buy | Chairman | 1,39,534 | 0.0780% | ||
| 01/06/23 | Buy | Director | 1,39,534 | 0.0780% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -95.11% | -91.54% | 18.7L | |
| +4.16% | +4.16% | +49.37% | +94.17% | 7.47TCr | |
| -0.07% | -1.37% | +23.00% | +78.84% | 5.88TCr | |
| -0.43% | +0.38% | +6.89% | +34.59% | 4.84TCr | |
| -1.48% | -2.25% | +329.09% | +698.20% | 4.28TCr | |
| -0.93% | -3.35% | +26.81% | +30.88% | 4.28TCr | |
| -0.43% | -0.68% | +5.30% | +108.64% | 4.12TCr | |
| -0.11% | +1.96% | +9.19% | +52.66% | 3.11TCr | |
| -2.07% | +1.16% | +35.00% | +26.28% | 3.03TCr | |
| -0.76% | -2.88% | -8.97% | -13.92% | 2.4TCr | |
| Average | -0.18% | -0.23% | +38.06% | +101.88% | 3.94TCr | |
| Weighted average by Cap. | +0.28% | -0.54% | +55.71% | +129.75% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 18.85L 13.16L 11.68L 10.93L 10L 18.72L 13Cr 1.31Cr 51.08L 6.47Cr 49.4L 48.34L 21Cr | 17.12L 11.95L 10.61L 10L 9L 16.99L 12Cr 1.19Cr 46.37L 5.88Cr 44.86L 43.89L 19Cr |
| Net income | -93.91L -65.56L -58.2L -54.46L -49.37L -93.23L -63Cr -6.54Cr -2.54Cr -32Cr -2.46Cr -2.41Cr -103.65Cr | -92.49L -64.57L -57.32L -53.64L -48.62L -91.82L -62Cr -6.44Cr -2.51Cr -32Cr -2.42Cr -2.37Cr -102.09Cr |
| Net Debt | -50.5L -35.26L -31.3L -29.29L -26.55L -50.13L -34Cr -3.52Cr -1.37Cr -17Cr -1.32Cr -1.29Cr -56Cr | -9L -6L -6L -5L -5L -9L -6.04Cr -62.51L -24.31L -3.08Cr -23.52L -23.01L -9.91Cr |
Employees
2
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | A$0.0110 | 0.00% | 1,70,628 |
| 02/26/02 | A$0.0110 | 0.00% | 2,96,490 |
| 30/26/30 | A$0.0110 | 0.00% | 40,951 |
| 29/26/29 | A$0.0110 | 0.00% | 6,46,884 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CYP Stock
Select your edition
All financial news and data tailored to specific country editions
